Left ventricular hypertrophy in chronic kidney disease

Introduction: Cardiovascular disease is a major cause of death in patients with chronic kidney disease (CKD). Mortality due to cardiovascular events is ten to twenty times greater than in general population. Left ventricular hypertrophy (LVH) is an independent predictor of mortality in chronic kidney disease patients. There are only a few studies which have looked at cardiovascular disease in Indian chronic kidney disease patients. Materials and Methods: This was a cross-sectional study of 100 consecutive chronic kidney disease patients in the nephrology department of our hospital. They were divided into mild, moderate and severe chronic kidney disease. The various parameters were then compared between these three groups using the Tukey’s test. A P value <0.05 was considered significant. Results: Out of the 100 patients, 69 had LVH. In the severe disease category, 39 patients (88.63%) had LVH. In the moderate group, 18 patients (51.42%) had LVH. In the mild group, 12 patients (57.14%) had LVH. Only anemia was found to correlate with the presence of LVH. Conclusion: A significant number of CKD patients had LVH and the highest numbers of LVH were found in the severe CKD group.